Teva Pharmaceutical Industries (TEVA) News Today $16.77 -0.76 (-4.34%) Closing price 05/30/2025 03:59 PM EasternExtended Trading$16.77 +0.00 (+0.03%) As of 05/30/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why is Teva Pharmaceutical Industries Dropping Today?Teva Pharmaceutical Industries Limited (NYSE:TEVA) TEVA shares have decreased today amid mixed analyst actions and ongoing strategic developments. Zacks Research raised its Q2 2025 EPS estimate for TEVA from $0.61 to $0.62, signaling stronger-than-expected near-term earnings potential. Truist Financial upgraded TEVA to a “strong-buy” rating and initiated coverage with a “buy” rating and a $25 price target, reflecting increased analyst confidence. The FDA granted fast track designation to TEV-‘408, Teva’s celiac disease candidate, potentially expediting its clinical development and approval timeline. Teva kicked off the acceleration phase of its “Pivot to Growth” strategy, aiming to build a $5 billion innovative medicines franchise by 2030 and drive long-term growth. Teva reaffirmed its 2027 financial targets—30% operating margin and over $2.7 billion in free cash flow—underscoring management’s commitment to its medium-term roadmap. Management issued aggressive guidance for its innovative drug portfolio, indicating confidence in upcoming product launches and pipeline performance. Despite these positive catalysts, TEVA shares traded down by approximately 4%, suggesting short-term selling pressure or profit-taking. Posted 1+ days agoAI Generated. May Contain Errors. TEVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period 15,048 Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Purchased by Jefferies Financial Group Inc.Jefferies Financial Group Inc. bought a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 15,048 shares of the company's stocJune 1 at 4:46 AM | marketbeat.comNew Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care ...May 31 at 7:12 PM | gurufocus.comTeva Pharmaceutical Industries Limited (TEVA) Highlights Long-Acting Injectable Advancements for Schizophrenia at 2025 Psych CongressMay 31 at 12:49 PM | insidermonkey.comZacks Research Issues Positive Outlook for TEVA EarningsTeva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research report issued to clients and investors on Wednesday, May 28th. Zacks Research analyst R. Department now expMay 31 at 5:52 AM | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Acquired by Centaurus Financial Inc.Centaurus Financial Inc. increased its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 97.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,279 shares of the company's sMay 31 at 4:51 AM | marketbeat.comSiemens Fonds Invest GmbH Invests $611,000 in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Siemens Fonds Invest GmbH acquired a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 27,722 sharesMay 31 at 4:43 AM | marketbeat.comNew Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025May 30 at 9:05 PM | globenewswire.comTeva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to DateMay 30 at 9:00 PM | globenewswire.comTeva Pharmaceutical Industries (NYSE:TEVA) Trading Down 4% - Should You Sell?Teva Pharmaceutical Industries (NYSE:TEVA) Shares Down 4% - What's Next?May 30 at 2:30 PM | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Stock Rating Upgraded by Truist FinancialTruist Financial raised Teva Pharmaceutical Industries to a "strong-buy" rating in a research report on Tuesday.May 30 at 7:49 AM | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by California State Teachers Retirement SystemCalifornia State Teachers Retirement System cut its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 8.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,241,262 sharesMay 30 at 5:52 AM | marketbeat.comTruist Financial Initiates Coverage on Teva Pharmaceutical Industries (NYSE:TEVA)May 30 at 1:51 AM | americanbankingnews.comTruist Initiates Teva Pharmaceuticals (TEVA) Coverage with Buy, $25 Price TargetMay 29 at 4:24 PM | msn.comTruist Securities Initiates Coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt () (TEVA) with Buy RecommendationMay 29 at 11:23 AM | msn.comTeva Reaffirms 2027 Targets, Aims for 30% Operating MarginMay 29 at 11:23 AM | msn.comTeva Pharmaceutical Industries (NYSE:TEVA) Earns Buy Rating from Analysts at Truist FinancialTruist Financial initiated coverage on Teva Pharmaceutical Industries in a research report on Wednesday. They issued a "buy" rating and a $25.00 price objective for the company.May 29 at 10:06 AM | marketbeat.comTeva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy DayMay 29 at 8:00 AM | globenewswire.comCapital A Wealth Management LLC Invests $596,000 in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Capital A Wealth Management LLC purchased a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 27,033 shMay 28, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408May 27, 2025 | insidermonkey.comTeva Celiac Disease Candidate Granted Fast Track Designation by US FDAMay 27, 2025 | globenewswire.comTeva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in JuneMay 27, 2025 | globenewswire.comWhy Is Teva Stock Trading Higher On Tuesday?May 27, 2025 | benzinga.comTeva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and AsthmaMay 27, 2025 | globenewswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 36,454 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 1.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange CommissioMay 27, 2025 | marketbeat.comRegulatory Shake-Up Led to the Sell Off in Teva Pharmaceutical Industries Limited (TEVA)May 26, 2025 | finance.yahoo.comRegulatory Shake-Up Led to the Sell Off in Teva Pharmaceutical Industries Limited (TEVA)May 26, 2025 | insidermonkey.comRoyal Bank of Canada Increases Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Royal Bank of Canada raised its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 17.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,177,603 shares of the company's stockMay 26, 2025 | marketbeat.comMan Group plc Has $954,000 Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Man Group plc lifted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 191.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 43,302 shares of the company's stock aMay 26, 2025 | marketbeat.comTwo Sigma Investments LP Sells 28,694 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Two Sigma Investments LP reduced its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 4.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 686,455 shares of the company's stMay 25, 2025 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Rating Increased to Buy at Wall Street ZenWall Street Zen raised shares of Teva Pharmaceutical Industries from a "hold" rating to a "buy" rating in a research note on Thursday.May 24, 2025 | marketbeat.comWorldquant Millennium Advisors LLC Invests $4.96 Million in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Worldquant Millennium Advisors LLC purchased a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 224,974 shares of theMay 24, 2025 | marketbeat.comWhy Investors Should Watch Teva Despite Regional RisksMay 23, 2025 | seekingalpha.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Acquired by Two Sigma Advisers LPTwo Sigma Advisers LP increased its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 57.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,630,600 shares of the cMay 23, 2025 | marketbeat.comTeva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 NotesMay 22, 2025 | globenewswire.comSoleus Capital Management L.P. Buys New Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Soleus Capital Management L.P. purchased a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,093,000 shareMay 21, 2025 | marketbeat.comNuveen Asset Management LLC Boosts Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Nuveen Asset Management LLC grew its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 6.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,857,007 shares of the company's stocMay 21, 2025 | marketbeat.comTeva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing DebtMay 20, 2025 | globenewswire.comTeva Pharmaceutical Industries Ltd (TEVA) Receives Credit Rating Upgrade from Fitch | TEVA ...May 20, 2025 | gurufocus.comFitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth StrategyMay 20, 2025 | globenewswire.comFitch upgrades Teva’s rating to ’BB+’ with stable outlookMay 20, 2025 | investing.comTema Etfs LLC Purchases New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Tema Etfs LLC purchased a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 25,662 shares of the company's stock, valued at approximately $May 20, 2025 | marketbeat.com27,722 Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Purchased by Siemens Fonds Invest GmbHSiemens Fonds Invest GmbH bought a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 27,722 shares of the cMay 20, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Lazard Asset Management LLCLazard Asset Management LLC decreased its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 56.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 103,230 shares of the company's sMay 20, 2025 | marketbeat.comJefferies Financial Group Inc. Takes $332,000 Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Jefferies Financial Group Inc. purchased a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 15,048 shares of the company's stock, vMay 20, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Given Consensus Rating of "Buy" by BrokeragesTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) has earned a consensus recommendation of "Buy" from the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation and one hMay 20, 2025 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Releases FY 2025 Earnings GuidanceTeva Pharmaceutical Industries (NYSE:TEVA) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.450-2.650 for the period, compared to the consensus estimate of 2.560. The company also issued revenue guidance of $16.8 billionillion-$17.2 billionillion, compared to the consensus estimate of $17.2 billionillion.May 19, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. Plans $2 Billion Senior Notes Offering to Finance Debt Tender OffersMay 19, 2025 | quiverquant.comTeva Pharmaceutical Industries Ltd. Launches Tender Offers for $2 Billion in Senior Notes to Optimize Debt StructureMay 19, 2025 | quiverquant.comTeva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031May 19, 2025 | globenewswire.comTeva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior NotesMay 19, 2025 | globenewswire.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.690.88▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼3412▲TEVA Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TAK News ARGX News ONC News BNTX News SMMT News ITCI News GMAB News RDY News MRNA News ASND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredMidnight trade alert: After-hours spike incoming??? Most traders don’t realize this… But the closing bell means jack $#!&. They hear the bell and they think...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TEVA Stock Free TEVA Stock Alerts